미국 D-비오틴 원료 가격 및 무역 — 마켓 오버뷰 2026

상위 제품

비오틴

HS 코드

293629

최종 업데이트

2026-08-23

서치 및 소싱 팀을 위한 핵심 요약

수출 파트너 국가 5개와 수입 파트너 국가 5개가 랭킹되어 있습니다.
이 페이지 데이터셋의 최신 기준 연도는 2024입니다.
페이지 데이터 최종 업데이트일: 2026-08-23.

미국 내 D-비오틴 원료 수출 공급업체 인텔리전스, 가격 추이 및 무역 흐름

Supply Chain Intelligence 기업 프로필 및 분석으로 미국의 D-비오틴 원료 수출업체 커버리지, 파트너 품질, 경로 우선순위를 검증하세요.

미국 내 D-비오틴 원료의 연간 수출 금액, 물량 및 공급업체 시장 규모 (HS 코드 293629)

미국의 D-비오틴 원료 수출 물량/금액 3년치를 분석해 공급 측 시장 성장, 계절성, 무역 변동성을 평가하세요.

연도	물량	금액
2024	674,243,494	6,469,815,386 USD
2023	642,836,987	5,688,944,770 USD
2022	671,832,255	6,015,844,115 USD

미국에서 수출되는 D-비오틴 원료의 주요 수출 대상 시장 (HS 코드 293629) 2024

2024년 기준, 미국발 D-비오틴 원료 수출의 상위 목적지국 5개 전반에서 수출 물량과 금액을 비교하세요.

순위	국가	물량	금액
1	캐나다	219,276,873	1,591,995,104 USD
2	멕시코	89,979,382	808,802,695 USD
3	대한민국	18,025,968	516,718,931 USD
4	중국	16,214,321	379,535,151 USD
5	네덜란드	14,503,360	219,345,936 USD

소싱 진단

미국산 D-비오틴 원료, 우리도 들여올 수 있을까요?

필요한 스펙과 물량만 알려주세요. 실제로 소싱이 되는지, 어떤 원산지와 공급사가 맞는지 무료로 짚어드려요.

미국의 D-비오틴 원료 수입 바이어 인텔리전스 및 가격 시그널: 바이어, 수요, 거래 파트너

수출업체와 수입업체는 Supply Chain Intelligence 기업 프로필 및 분석으로 미국의 D-비오틴 원료 구매 수요, 파트너 밀도, 다운스트림 채널을 분석할 수 있습니다.

미국 내 D-비오틴 원료의 연간 수입 금액, 물량 및 수요 규모 (HS 코드 293629)

미국의 D-비오틴 원료 수입 물량/금액 3년치를 추적해 수요 성장과 시장 모멘텀을 평가하세요.

연도	물량	금액
2024	898,294,665	6,939,916,965 USD
2023	781,730,176	6,824,395,492 USD
2022	808,472,607	8,090,713,195 USD

미국에 D-비오틴 원료를 공급하는 주요 원산지 공급국 (HS 코드 293629) 2024

2024년 기준, 미국로 D-비오틴 원료를 공급하는 상위 원산 공급국 5개 전반의 수입 물량과 금액을 비교하세요.

순위	국가	물량	금액
1	싱가포르	9,166,996	2,697,397,964 USD
2	캐나다	274,083,727	1,065,799,527 USD
3	중국	89,612,974	566,159,486 USD
4	멕시코	67,952,928	258,053,571 USD
5	독일	17,249,413	203,664,029 USD

수출 진단

우리 D-비오틴 원료, 이 미국 바이어들에게 팔 수 있을까요?

만드시는 제품만 알려주시면 됩니다. 지금 수출할 준비가 됐는지, 어느 시장이 맞는지 무료로 봐드려요.

가격 데이터

가려진 미국 D-비오틴 원료 가격, 열어볼까요?

전체 가격 히스토리와 경쟁사 벤치마크를 열어드립니다. 어떤 숫자가 필요하신지만 말씀해 주시면 함께 살펴봐 드려요.

Classification

Product TypeProcessed Food

Product FormFinished dietary supplement (oral solid dosage; e.g., capsule/tablet/softgel/gummy)

Industry PositionFinished Consumer Health Product (Dietary Supplement)

Market

Biotin (vitamin B7) supplements are widely available in the United States through retail and online channels and are marketed as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA). FDA does not approve dietary supplements for safety or effectiveness before they are marketed; firms are responsible for product safety, quality, and labeling compliance. Demand is strongly tied to consumer interest in hair/skin/nails and general wellness positioning, but evidence for some marketed benefits can be limited depending on the claim and population. High-dose biotin use is a practical safety concern in the U.S. because it can interfere with certain laboratory tests, and FDA has issued communications on this issue.

Market RoleMajor consumer market with substantial domestic manufacturing and significant import supply of dietary ingredients and finished supplements

Domestic RoleMainstream over-the-counter wellness supplement category sold via mass retail, pharmacies, and e-commerce

Specification

Physical Attributes

Common U.S. market formats include tablets, capsules, softgels, powders, gummies, and liquids

Compositional Metrics

Label declaration typically uses micrograms (mcg) or milligrams (mg) per serving on the Supplement Facts panel

Packaging

Retail-ready consumer packaging with required Supplement Facts labeling and dietary supplement identity statement

Supply Chain

Value Chain

Dietary ingredient sourcing (domestic/import) → receiving & QC → weighing/dispensing → blending → encapsulation/tableting/softgel fill (or gummy manufacture) → packaging & labeling → finished product release → distribution to retail and e-commerce

Temperature

Typically handled as ambient-stable finished goods; storage conditions follow product labeling and quality system requirements

Freight IntensityLow

Transport ModeMultimodal

Risks

Regulatory Compliance HighNoncompliance with U.S. dietary supplement requirements (e.g., cGMP failures under 21 CFR Part 111, misbranding, or impermissible disease claims) can trigger FDA enforcement, including recalls, seizures/injunctions, and import examination/detention for noncompliant products.Operate under 21 CFR Part 111-aligned quality systems; perform label and claim substantiation review; qualify suppliers and maintain complete batch/quality records to support inspections and investigations.

Medical Safety MediumBiotin in supplements can significantly interfere with certain laboratory tests (including some troponin assays), creating a risk of incorrect results and potential patient harm if biotin use is not disclosed.Include clear consumer guidance consistent with FDA communications (e.g., advise notifying healthcare providers about biotin use) and maintain robust complaint handling for lab-test interference reports.

Advertising Claims MediumMarketing claims for supplements are scrutinized by U.S. regulators; unsupported or misleading health-related claims can lead to FTC enforcement and reputational damage.Maintain claim substantiation files (competent and reliable scientific evidence) and ensure marketing aligns with FTC health products compliance guidance.

Food Safety MediumQuality failures such as ingredient identity/purity issues or label-claim inaccuracies can lead to consumer risk, recalls, and retailer delisting in the U.S. market.Use qualified testing (identity/strength/contaminants) and consider credible third-party verification programs (e.g., NSF/ANSI 173 or USP verification) for higher-risk channels.

Standards

NSF/ANSI 173 dietary supplement certification (where required by buyers or used as a quality signal)
USP Dietary Supplement Verification Program (where used as a quality signal)

FAQ

Does the FDA approve biotin supplements before they are sold in the United States?No. Under U.S. law, FDA does not approve dietary supplements for safety or effectiveness before they are marketed. Companies are responsible for ensuring their products are safe and properly labeled, and FDA’s oversight largely occurs after products are on the market.

What is the main U.S. manufacturing compliance standard for biotin dietary supplements?Dietary supplement manufacturers and related operations are expected to follow FDA’s dietary supplement cGMP requirements in 21 CFR Part 111, which focus on quality systems, production/process controls, and documentation.

Why is biotin supplementation considered a safety risk for lab testing in the U.S.?FDA has warned that biotin—often found in supplements—can significantly interfere with certain laboratory tests and produce incorrect results that may go undetected. Consumers are advised to inform healthcare providers and laboratories if they are taking biotin.